Sunday - April 5, 2026
University of Missouri: ABK Biomedical and MURR Forge Long-term Partnership to Advance Breakthrough Cancer Therapy
April 01, 2026
COLUMBIA, Missouri, April 1 -- The University of Missouri issued the following news release:

* * *

ABK Biomedical and MURR forge long-term partnership to advance breakthrough cancer therapy

A new agreement names MURR as the primary irradiation partner for ABK Biomedical's Eye90 microspheres.

By Uriah Orland

ABK Biomedical and the University of Missouri Research Reactor (MURR) are powering the next generation of cancer treatmen . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Name:
What's your
Affiliation		 Government Newspaper / Media Business
Public Policy Individual / Student Educators
Email:
Phone:
Organization, if any:
State/Country you are in:
Additonal questions
or comments:

Click here for more information about our products

Click here for more information about our products